clemastine and guaifenesin

clemastine has been researched along with guaifenesin in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (33.33)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (66.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Edelman, DA; Gwaltney, JM; O'Connor, RR; Park, J; Paul, RA; Turner, RB	1

Reviews

1 review(s) available for clemastine and guaifenesin

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Trials

1 trial(s) available for clemastine and guaifenesin

Article	Year
Randomized controlled trial of clemastine fumarate for treatment of experimental rhinovirus colds. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1996, Volume: 22, Issue:4 Topics: Administration, Intranasal; Adolescent; Adult; Clemastine; Common Cold; Double-Blind Method; Female; Histamine H1 Antagonists; Humans; Male; Middle Aged; Mucus; Nasal Mucosa; Nasal Obstruction; Placebos; Rhinovirus; Sneezing; Xerostomia	1996

Article

Year

Randomized controlled trial of clemastine fumarate for treatment of experimental rhinovirus colds.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1996, Volume: 22, Issue:4

Topics: Administration, Intranasal; Adolescent; Adult; Clemastine; Common Cold; Double-Blind Method; Female; Histamine H1 Antagonists; Humans; Male; Middle Aged; Mucus; Nasal Mucosa; Nasal Obstruction; Placebos; Rhinovirus; Sneezing; Xerostomia

1996

Other Studies

1 other study(ies) available for clemastine and guaifenesin

Article	Year
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds. Chemical research in toxicology, 2012, Oct-15, Volume: 25, Issue:10 Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding	2012

Article

Year

Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.

Chemical research in toxicology, 2012, Oct-15, Volume: 25, Issue:10

Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding

2012